Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Biovision Ventures is a venture capital firm based in Paphos, Cyprus, with a presence in Berlin, Germany. The firm focuses on early-stage investments in life sciences and healthcare, managing a small team of two key members. Notable exits include Retrosense Therapeutics and Bonti, showcasing their active role in the venture capital landscape.
Biovision Ventures invests in therapeutics and Bio-IT solutions, targeting companies from Seed to Series B stages. The firm prioritizes novel platform-based therapeutic approaches with strong intellectual property protection and solutions addressing unmet clinical needs. Their investment strategy spans globally, with a particular emphasis on North America and Europe.
Notable portfolio companies include Tune Therapeutics, Retrosense Therapeutics, acquired by Allergan for $555 million in 2016, and Bonti, acquired by Allergan for $285 million in 2018. Hawthorne Health also features in their portfolio, with Igor Gonikhin serving on its board.
Alexey Konov, PhD - Managing Partner, has extensive experience in life sciences and serves on the boards of several portfolio companies. Igor Gonikhin, CFA - Partner, brings financial expertise and also serves on the board of Hawthorne Health.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.